Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approach.
about
Mammalian target of rapamycin inhibitor-associated stomatitisOral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review.Expression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma.
P2860
Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approach.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemic therapy for metastati ...... tients: a risk-based approach.
@en
Systemic therapy for metastati ...... tients: a risk-based approach.
@nl
type
label
Systemic therapy for metastati ...... tients: a risk-based approach.
@en
Systemic therapy for metastati ...... tients: a risk-based approach.
@nl
prefLabel
Systemic therapy for metastati ...... tients: a risk-based approach.
@en
Systemic therapy for metastati ...... tients: a risk-based approach.
@nl
P2860
P1476
Systemic therapy for metastati ...... tients: a risk-based approach.
@en
P2093
Ronald M Bukowski
P2860
P304
P356
10.1517/14656566.2010.499126
P407
P577
2010-10-01T00:00:00Z